22Q11 DELETION SYNDROME
Clinical trials for 22Q11 DELETION SYNDROME explained in plain language.
Never miss a new study
Get alerted when new 22Q11 DELETION SYNDROME trials appear
Sign up with your email to follow new studies for 22Q11 DELETION SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
A common antidepressant may tame anxiety in kids with autism and ADHD — a trial puts it to the test
Symptom relief Recruiting nowThis trial tests whether sertraline, a widely used antidepressant, can reduce anxiety in children and teens aged 8 to 17 with neurodevelopmental disorders such as autism, ADHD, Fragile X syndrome, and Tourette syndrome. Participants receive either sertraline or a placebo for seve…
Matched conditions: 22Q11 DELETION SYNDROME
Phase: PHASE2 • Sponsor: Holland Bloorview Kids Rehabilitation Hospital • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Could a headset boost brainpower in teens with a rare genetic condition?
Symptom relief Recruiting nowThis study tests whether a gentle brain stimulation technique called tACS, used at home for 5 days a week over 4 weeks, can improve memory and thinking in 40 young people aged 14-25 with 22q11.2 deletion syndrome. The stimulation is personalized based on each participant's MRI an…
Matched conditions: 22Q11 DELETION SYNDROME
Phase: NA • Sponsor: Stephan Eliez • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC